Data4Life and Monash Health Announce Strategic Collaboration to Advance Clinical Research
mehr
Meldungen zum Thema Medizinische Forschung
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich
Aachen, Germany (ots) - Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic ...
mehrTechnische Universität München
Stem Cell Research: Reading Genetic Activity from Living Cells without Destroying Them
TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE Tool for Better Control of Stem Cell Development Reading Genetic Activity from Living Cells without Destroying Them - Multi-day gene activity profiles from the same cells - Long-term analysis of cell communication in mixed cultures - Potential applications in organoids and tumor microenvironments Until now, studying the ...
mehr100,000 Participants Screened for Early-Stage Type 1 Diabetes in the EDENT1FI Project
EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an important milestone toward its goal, having screened 100,000 of the more than 200,000 children and adolescents ...
mehrXlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity
mehrAsklepios Kliniken GmbH & Co. KGaA
Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award
Wiesbaden, Germany (ots) - - Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy - One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time - Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical ...
mehr
Letter of Intent for strategic partnership / Vaccentis and TrueMed join forces to advance cancer vaccine
Zurich (ots) - Vaccentis, a Zurich based biotech company specializing in the development of therapeutic protein-based tumor vaccines, has signed a letter of intent with TrueMed, a leading commercialization partner. Accelerating cancer vaccine against renal cell carcinoma The aim of this letter of intent is to ...
mehrMaP Toolbox: Your Hub for Master Protocol Clinical Trials
mehrData4Life and EvidNet form strategic partnership to advance federated real-world evidence generation
Seoul, South Korea & Potsdam, Germany (ots) - Data2Evidence meets FeederNet: Joining forces for scalable, standardized, and responsible health research infrastructure Nonprofit digital health organization Data4Life and South Korea’s leading federated research platform EvidNet today announced a strategic ...
mehrAsklepios Kliniken GmbH & Co. KGaA
2Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025
mehrAsklepios Kliniken GmbH & Co. KGaA
Nominations for the Broermann Medical Innovation Award 2026 now open
Hamburg (ots) - - With a million euros, it is one of the world’s most highly endowed awards for medical research The nomination period for the Broermann Medical Innovation Award 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made ...
mehr- 2
New Endoscopy Technology Enables Early Detection of Esophageal Cancer
mehr
Technische Universität München
A new biotech hub for Munich
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE A new biotech hub for Munich Where science powers start-ups: Launching BioLabs|TUM • TUM Venture Labs cooperate with BioLabs and Lilly • 1,800 square meters of coworking lab space • Aiming at accelerating therapy development BioLabs, TUM Venture Labs, and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in central Munich. The initiative aims to empower early-stage biotech start-ups ...
mehrTherapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients
mehrTherVacB: Advance Curative Strategy for Chronic Hepatitis B
mehrCancer Cachexia: Liver Identified as Driver of Body Wasting
Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...
mehr- 2
New Label-Free Imaging Tracks Cancer Treatment in Single Cells
mehr Less than 30 days left to apply – don’t miss your chance
Ein Dokumentmehr
- 3
Key technology for bioprocesses
mehr AI Meets Game Theory: How Language Models Perform in Human-Like Social Scenarios
mehrcanSERV Open Call relaunches: Apply now for Free Access to Cutting-Edge Cancer Research Services
Ein DokumentmehrSGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension Treatment
mehrNew Knowledge Portal Adiposetissue.org Enhances Obesity and Metabolism Research with Centralized Data
mehrAsklepios Kliniken GmbH & Co. KGaA
Nomination period for the Broermann Medical Innovation Award started
Gießen (ots) - - Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is ...
mehr
SCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
mehrTechnische Universität München
Complex pancreatic tumor organoids as foundation for new treatment strategies
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Foundation for new cancer treatment strategies Organoids represent the complex cell landscape of pancreatic cancer - Tumors are composed of cancer cells with a variety of different characteristics. - This contributes significantly to the complexity of pancreatic cancer and makes the disease difficult to treat. - For the ...
mehrInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
mehrLast Call for canSERV Third Open Call Funding
Ein DokumentmehrExtreme Rainfall Poses Health Risks
Extreme Rainfall Poses Health Risks An international study led by Helmholtz Munich investigates the health consequences of heavy rainfall events. Researchers analyzed the relationship between precipitation patterns and mortality rates at 645 locations across 34 countries from 1980 to 2020. The key finding: Extremely heavy rainfall, which occurs approximately every five years, significantly increases the risk of death, ...
mehrLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
Ein Dokumentmehr
12Nächste